{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:16:22Z","timestamp":1784081782984,"version":"3.55.0"},"reference-count":70,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Neisseria gonorrhoeae (N. gonorrhoeae) is the etiological agent of the second most common sexually transmitted disease in the world, gonorrhoea. Currently recommended and last available first-line therapy is extended-spectrum cephalosporins most often combined with azitromycin. However, misuse of antibiotics and the abilities of N. gonorrhoeae to acquire new genetic and plasmid-borne resistance determinants has gradually led to the situation where this bacterium has become resistant to all major classes of antibiotics. Together with a generally slow update of treatment guidelines globally, as well as with the high capacity of gonococci to develop and retain AMR, this may lead to the global worsening of gonococcal AMR. Since effective vaccines are unavailable, the management of gonorrhoea relies mostly on prevention and accurate diagnosis, together with antimicrobial treatment. The study overviews the latest results of mostly WHO-initiated studies, primarily focusing on the data regarding the molecular basis of the resistance to the current and novel most promising antibacterial agents, which could serve to establish or reinforce the continual, quality-assured and comparable AMR surveillance, including systematic monitoring and treatment with the use of molecular AMR prediction methods.<\/jats:p>","DOI":"10.3390\/pathogens11111230","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T05:11:33Z","timestamp":1666761093000},"page":"1230","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Current Susceptibility Surveillance and Distribution of Antimicrobial Resistance in N. gonorrheae within WHO Regions"],"prefix":"10.3390","volume":"11","author":[{"given":"Marina","family":"Radovanovic","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Institute for Biological Research \u201cSini\u0161a Stankovi\u0107\u201d, University of Belgrade, Belgrade 11000, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0327-4838","authenticated-orcid":false,"given":"Dusan","family":"Kekic","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade 11000, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos","family":"Jovicevic","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade 11000, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3727-6583","authenticated-orcid":false,"given":"Jovana","family":"Kabic","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade 11000, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1578-2776","authenticated-orcid":false,"given":"Ina","family":"Gajic","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade 11000, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8765-4044","authenticated-orcid":false,"given":"Natasa","family":"Opavski","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade 11000, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazar","family":"Ranin","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, Belgrade 11000, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro.2017.169","article-title":"Neisseria gonorrhoeae host adaptation and pathogenesis","volume":"16","author":"Quillin","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1071\/SH19023","article-title":"World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): Review of new data and evidence to inform international collaborative actions and research efforts","volume":"16","author":"Unemo","year":"2019","journal-title":"Sex. Health"},{"key":"ref_3","unstructured":"(2022, October 17). Sexually Transmitted Disease Surveillance, Available online: https:\/\/www.cdc.gov\/std\/statistics\/2020\/default.htm."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5758387","DOI":"10.1155\/2016\/5758387","article-title":"Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature","volume":"2016","author":"Chan","year":"2016","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/IM9.0000000000000024","article-title":"Antibiotic Resistance and Treatment Options for Multidrug-Resistant Gonorrhea","volume":"2","author":"Yang","year":"2020","journal-title":"Infect. Microbes Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: Past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"20862","DOI":"10.2807\/1560-7917.ES2014.19.30.20862","article-title":"Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014","volume":"19","author":"Golparian","year":"2014","journal-title":"Euro Surveill."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Unemo, M. (2015). Current and future antimicrobial treatment of gonorrhea\u2014The rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect. Dis., 15.","DOI":"10.1186\/s12879-015-1029-2"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1093\/cid\/ciac043","article-title":"Management of Neisseria gonorrhoeae in the United States: Summary of Evidence from the Development of the 2020 Gonorrhea Treatment Recommendations and the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Treatment Guidelines","volume":"74","author":"Barbee","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/0956462420948739","article-title":"Background review for the \u201c2020 European guideline for the diagnosis and treatment of gonorrhoea in adults\u201d","volume":"32","author":"Unemo","year":"2021","journal-title":"Int. J. STD AIDS"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1800617","DOI":"10.2807\/1560-7917.ES.2018.23.47.1800617","article-title":"Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018","volume":"23","author":"Golparian","year":"2018","journal-title":"Euro Surveill."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMc1512757","article-title":"Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea","volume":"374","author":"Fifer","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1473-3099(18)30340-2","article-title":"Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin","volume":"18","author":"Whiley","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1900118","DOI":"10.2807\/1560-7917.ES.2019.24.8.1900118","article-title":"Genetic relatedness of ceftriaxone-resistant and highlevel azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018","volume":"24","author":"Jennison","year":"2019","journal-title":"Eurosurveillance"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/S2666-5247(22)00044-1","article-title":"Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: A genomic surveillance study","volume":"3","author":"Cole","year":"2022","journal-title":"Lancet Microbe"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1093\/jac\/dky162","article-title":"In vitro activity of the novel triazaacenaphthylene gepotidacin (GSK2140944) against MDR Neisseria gonorrhoeae","volume":"73","author":"Jacobsson","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e01221-18","DOI":"10.1128\/AAC.01221-18","article-title":"Microbiological analysis from a phase 2 randomized study in adults evaluating single oral doses of gepotidacin in the treatment of uncomplicated urogenital gonorrhea caused by neisseria gonorrhoeae","volume":"62","author":"Hossain","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"11827","DOI":"10.1038\/srep11827","article-title":"Responding to the challenge of untreatable gonorrhea: ETX0914, a first-in-class agent with a distinct mechanism-of-action against bacterial Type II topoisomerases","volume":"5","author":"Basarab","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea","volume":"7","author":"Unemo","year":"2012","journal-title":"Future Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1046\/j.1365-2958.2002.03265.x","article-title":"An inhibitor of DNA binding and uptake events dictates the proficiency of genetic transformation in Neisseria gonorrhoeae: Mechanism of action and links to Type IV pilus expression","volume":"46","author":"Aas","year":"2002","journal-title":"Mol. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1365-2958.2005.04964.x","article-title":"Natural transformation of Neisseria gonorrhoeae: From DNA donation to homologous recombination","volume":"59","author":"Hamilton","year":"2006","journal-title":"Mol. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1128\/jb.176.2.333-337.1994","article-title":"Interspecies recombination between the penA genes of Neisseria meningitidis and commensal Neisseria species during the emergence of penicillin resistance in N. meningitidis: Natural events and laboratory simulation","volume":"176","author":"Bowler","year":"1994","journal-title":"J. Bacteriol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e02069-17","DOI":"10.1128\/AAC.02069-17","article-title":"Neisseria cinerea with high ceftriaxone MIC Is a source of ceftriaxone and cefixime resistance-mediating penA sequences in Neisseria gonorrhoeae","volume":"62","author":"Igawa","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1128\/JCM.00100-17","article-title":"Neisseria gonorrhoeae sequence typing for antimicrobial resistance, a novel antimicrobial resistance multilocus typing scheme for tracking global dissemination of N. Gonorrhoeae strains","volume":"55","author":"Demczuk","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1074\/jbc.RA120.012617","article-title":"Mutations in penicillin-binding protein 2 from cephalosporin-resistant Neisseria gonorrhoeae hinder ceftriaxone acylation by restricting protein dynamics","volume":"295","author":"Singh","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1099\/13500872-141-3-611","article-title":"Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system","volume":"141 Pt 3","author":"Hagman","year":"1995","journal-title":"Microbiology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1365-2958.2005.04752.x","article-title":"The penC mutation conferring antibiotic resistance in Neisseria gonorrhoeae arises from a mutation in the PilQ secretin that interferes with multimer stability","volume":"57","author":"Zhao","year":"2005","journal-title":"Mol. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Muhammad, I., Golparian, D., Dillon, J.A.R., Johansson, \u00c5., Ohnishi, M., Sethi, S., Chen, S.-C., Nakayama, S.-I., Sundqvist, M., and Bala, M. (2014). Characterisation of bla TEM genes and types of \u03b2-lactamase plasmids in Neisseria gonorrhoeae\u2014The prevalent and conserved bla TEM-135 has not recently evolved and existed in the Toronto plasmid from the origin. BMC Infect. Dis., 14.","DOI":"10.1186\/1471-2334-14-454"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kivata, M.W., Mbuchi, M., Eyase, F., Bulimo, W.D., Kyanya, C.K., Oundo, V., Mbinda, W.M., Sang, W., Andagalu, B., and Soge, O.O. (2020). Plasmid mediated penicillin and tetracycline resistance among Neisseria gonorrhoeae isolates from Kenya. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05398-5"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1093\/jac\/dkz306","article-title":"A \u03b2-lactamase-producing plasmid from Neisseria gonorrhoeae carrying a unique 6 bp deletion in blaTEM-1 encoding a truncated 24 kDa TEM-1 penicillinase that hydrolyses ampicillin slowly","volume":"74","author":"Singh","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijantimicag.2019.06.012","article-title":"High prevalence of TEM-135 expression from the Asian plasmid in penicillinase-producing Neisseria gonorrhoeae from Hangzhou, China","volume":"54","author":"Yan","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Shaskolskiy, B., Kandinov, I., Dementieva, E., and Gryadunov, D. (2022). Antibiotic Resistance in Neisseria gonorrhoeae: Challenges in Research and Treatment. Microorganisms, 10.","DOI":"10.3390\/microorganisms10091699"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"iv5","DOI":"10.1136\/sextrans-2013-051162","article-title":"Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: The Gonococcal Isolate Surveillance Project (GISP), January 2006-June 2012","volume":"89","author":"Kirkcaldy","year":"2013","journal-title":"Sex. Transm. Infect."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6507a1","article-title":"Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance\u2014The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. MMWR","volume":"65","author":"Kirkcaldy","year":"2016","journal-title":"Surveill. Summ."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3201\/eid2201.151247","article-title":"Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada","volume":"22","author":"Martin","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/OLQ.0000000000000603","article-title":"Emergence and spread of neisseria gonorrhoeae isolates with decreased susceptibility to extended-spectrum cephalosporins in Argentina, 2009 to 2013","volume":"44","author":"Gianecini","year":"2017","journal-title":"Sex. Transm. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/sextrans-2016-052583","article-title":"Drifting towards ceftriaxone treatment failure in gonorrhoea: Risk factor analysis of data from the Gonococcal Resistance to Antimicrobials Surveillance Programme in England and Wales","volume":"93","author":"Town","year":"2017","journal-title":"Sex. Transm. Infect."},{"key":"ref_38","unstructured":"(2022, September 29). EUCAST: Clinical Breakpoints and Dosing of Antibiotics. Available online: https:\/\/www.eucast.org\/clinical_breakpoints."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"iv42","DOI":"10.1136\/sextrans-2012-050909","article-title":"Gonorrhoea and gonococcal antimicrobial resistance surveillance networks in the WHO European Region, including the independent countries of the former Soviet Union","volume":"89","author":"Unemo","year":"2013","journal-title":"Sex. Transm. Infect."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/apm.12948","article-title":"Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013\u20132018","volume":"127","author":"Boiko","year":"2019","journal-title":"APMIS"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Day, M.J., Jacobsson, S., Spiteri, G., Kulishev, C., Sajedi, N., Woodford, N., Blumel, B., van der Werf, M.J., Amato-Gauci, A.J., and Unemo, M. (2022). Significant increase in azithromycin \u201cresistance\u201d and susceptibility to ceftriaxone and cefixime in Neisseria gonorrhoeae isolates in 26 European countries, 2019. BMC Infect. Dis., 22.","DOI":"10.1186\/s12879-022-07509-w"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e00863-20","DOI":"10.1128\/AAC.00863-20","article-title":"Susceptibility trends of zoliflodacin against multidrug-resistant neisseria gonorrhoeae clinical isolates in nanjing, china, 2014 to 2018","volume":"65","author":"Le","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Wi, T., Lahra, M.M., Ndowa, F., Bala, M., Dillon, J.A.R., Ramon-Pardo, P., Eremin, S.R., Bolan, G., and Unemo, M. (2017). Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002344"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e17009","DOI":"10.2196\/17009","article-title":"Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implemented Surveillance Program in Uganda: Surveillance Report","volume":"6","author":"Workneh","year":"2020","journal-title":"JMIR Public Health Surveill."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e00906-20","DOI":"10.1128\/AAC.00906-20","article-title":"Antimicrobial resistance of Neisseria gonorrhoeae isolates from high-risk men in Johannesburg, South Africa","volume":"64","author":"Maduna","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/OLQ.0000000000000961","article-title":"Resistance Profile of Neisseria gonorrhoeae in KwaZulu-Natal, South Africa Questioning the Effect of the Currently Advocated Dual Therapy","volume":"46","author":"Rambaran","year":"2019","journal-title":"Sex. Transm. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/0956462419897227","article-title":"Sharp increase in ciprofloxacin resistance of Neisseria gonorrhoeae in Yaounde, Cameroon: Analyses of a laboratory database period 2012\u20132018","volume":"31","author":"Crucitti","year":"2020","journal-title":"Int. J. STD AIDS"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"iv24","DOI":"10.1136\/sextrans-2013-051166","article-title":"Antimicrobial resistance monitoring in Neisseria gonorrhoeae and strategic use of funds from the Global Fund to set up a systematic Moroccan gonococcal antimicrobial surveillance programme","volume":"89","author":"Ndowa","year":"2013","journal-title":"Sex. Transm. Infect."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Al-Maslamani, M., Elmagboul, E.B.I., Puthiyottil, A., Chemaitelly, H., Varghese, M.K., Al Romaihi, H.E., Al-Thani, M.H., Al Khal, A., Unemo, M., and Abu-Raddad, L.J. (2022). First characterisation of antimicrobial susceptibility and resistance of Neisseria gonorrhoeae isolates in Qatar, 2017\u20132020. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0264737"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Nguyen, P.T.T., Pham, H.V., Van, D.H., Van Pham, L., Nguyen, H.T., and Van Nguyen, H. (2022). Randomized controlled trial of the relative efficacy of high-dose intravenous ceftriaxone and oral cefixime combined with doxycycline for the treatment of Chlamydia trachomatis and Neisseria gonorrhoeae co-infection. BMC Infect. Dis., 22.","DOI":"10.1186\/s12879-022-07595-w"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"7263849","DOI":"10.1155\/2018\/7263849","article-title":"Molecular Antimicrobial Resistance of Neisseria gonorrhoeae in a Moroccan Area","volume":"2018","author":"Karim","year":"2018","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Cole, M.J., Quinten, C., Jacobsson, S., Day, M., Amato-Gauci, A.J., Woodford, N., Spiteri, G., Unemo, M., Stary, A., and Haller, M. (2019). The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union\/European Economic Area. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-4631-x"},{"key":"ref_53","unstructured":"(2022, August 28). Gonococcal Antimicrobial Susceptibility Surveillance in the European Union\/European Economic Area. Available online: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/gonococcal-antimicrobial-susceptibility-surveillance-2019."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"20358","DOI":"10.2807\/ese.18.03.20358-en","article-title":"Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrugresistant clone","volume":"18","author":"Chisholm","year":"2013","journal-title":"Eurosurveillance"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1473-3099(18)30225-1","article-title":"Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: A genomic survey","volume":"18","author":"Harris","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0956462412472837","article-title":"2012 European guideline on the diagnosis and treatment of gonorrhoea in adults","volume":"24","author":"Bignell","year":"2013","journal-title":"Int. J. STD AIDS"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Cole, M.J., Spiteri, G., Jacobsson, S., Woodford, N., Tripodo, F., Amato-Gauci, A.J., Unemo, M., Indra, A., Maes, V., and Crucitti, T. (2017). Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2707-z"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Golparian, D., Harris, S.R., S\u00e1nchez-Bus\u00f3, L., Hoffmann, S., Shafer, W.M., Bentley, S.D., Jensen, J.S., and Unemo, M. (2020). Genomic evolution of Neisseria gonorrhoeae since the preantibiotic era (1928-2013): Antimicrobial use\/misuse selects for resistance and drives evolution. BMC Genomics, 21.","DOI":"10.1186\/s12864-020-6511-6"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jac\/dkab024","article-title":"High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018","volume":"76","author":"Unemo","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_60","first-page":"225","article-title":"Horizontal Gene Transfer of Fluoroquinolone Resistance-Conferring Genes From Commensal Neisseria to Neisseria gonorrhoeae: A Global Phylogenetic Analysis of 20,047 Isolates","volume":"13","author":"Laumen","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Shaskolskiy, B., Dementieva, E., Kandinov, I., Filippova, M., Petrova, N., Plakhova, X., Chestkov, A., Kubanov, A., Deryabin, D., and Gryadunov, D. (2019). Resistance of Neisseria gonorrhoeae isolates to beta-lactam antibiotics (benzylpenicillin and ceftriaxone) in Russia, 2015\u20132017. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0220339"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.meegid.2018.06.003","article-title":"Tetracycline resistance of Neisseria gonorrhoeae in Russia, 2015\u20132017","volume":"63","author":"Shaskolskiy","year":"2018","journal-title":"Infect. Genet. Evol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e02024-18","DOI":"10.1128\/JCM.02024-18","article-title":"Summary and Trends of the Russian Gonococcal Antimicrobial Surveillance Programme, 2005 to 2016","volume":"57","author":"Kubanov","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Shaskolskiy, B., Kandinov, I., Kravtsov, D., Vinokurova, A., Gorshkova, S., Filippova, M., Kubanov, A., Solomka, V., Deryabin, D., and Dementieva, E. (2021). Hydrogel Droplet Microarray for Genotyping Antimicrobial Resistance Determinants in Neisseria gonorrhoeae Isolates. Polymers, 13.","DOI":"10.3390\/polym13223889"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Pachulec, E., and van der Does, C. (2010). Conjugative Plasmids of Neisseria gonorrhoeae. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009962"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev-genet-120213-092007","article-title":"The Genetics of Neisseria Species","volume":"48","author":"Rotman","year":"2014","journal-title":"Annu. Rev. Genet."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Aniskevich, A., Shimanskaya, I., Boiko, I., Golubovskaya, T., Golparian, D., Stanislavova, I., Jacobsson, S., Adaskevich, A., and Unemo, M. (2021). Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009\u20132019. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-06184-7"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.3389\/fmicb.2020.580399","article-title":"Shanghai Neisseria gonorrhoeae Isolates Exhibit Resistance to Extended-Spectrum Cephalosporins and Clonal Distribution","volume":"11","author":"Dong","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00007435-199004000-00004","article-title":"Acquisition of beta-lactamase and TetM-containing conjugative plasmids by phenotypically different strains of Neisseria gonorrhoeae","volume":"17","author":"Sarafian","year":"1990","journal-title":"Sex. Transm. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e00109-22","DOI":"10.1128\/aac.00109-22","article-title":"In Vitro Activity of Ertapenem against Neisseria gonorrhoeae Clinical Isolates with Decreased Susceptibility or Resistance to Extended-Spectrum Cephalosporins in Nanjing, China (2013 to 2019)","volume":"66","author":"Li","year":"2022","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/11\/11\/1230\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:02:21Z","timestamp":1760144541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/11\/11\/1230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":70,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["pathogens11111230"],"URL":"https:\/\/doi.org\/10.3390\/pathogens11111230","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,25]]}}}